Moguisteine

From WikiMD's Wellnesspedia

Moguisteine is a cough suppressant or antitussive that was discovered in the 1980s. It is a non-narcotic medication, meaning it does not have the potential for misuse that some other cough suppressants do. Moguisteine works by reducing the activity of the cough center in the brain, which can decrease the urge to cough.

History[edit | edit source]

Moguisteine was first synthesized in the 1980s by a team of researchers at the Mogu Pharmaceuticals company. The team was searching for a new, non-narcotic cough suppressant that would be effective without the risk of misuse or addiction. After extensive testing, they discovered moguisteine, which showed promise in both animal and human trials.

Pharmacology[edit | edit source]

Moguisteine is a peripheral antitussive, which means it works by reducing the activity of the cough center in the brain. This can decrease the urge to cough, making it useful for treating conditions such as chronic bronchitis and cough variant asthma.

Moguisteine is metabolized in the liver and excreted in the urine. It has a half-life of about 2-3 hours, which means it needs to be taken several times a day to maintain its effect.

Side Effects[edit | edit source]

Like all medications, moguisteine can cause side effects. These can include nausea, vomiting, dizziness, and drowsiness. In rare cases, it can cause more serious side effects such as allergic reactions or respiratory depression.

Availability[edit | edit source]

Moguisteine is available in many countries around the world, including Japan, South Korea, and several countries in Europe. However, it is not currently approved for use in the United States.

See Also[edit | edit source]


Moguisteine Resources

Find a healthcare provider anywhere in the world quickly and easily!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.


Contributors: Prab R. Tumpati, MD